Maintenance: On Thursday, June 28 2018, 18:00-18:15, maintenance work on the ZORA servers is scheduled. ZORA will not be available during this period. Thank you for your patience.
Guerreiro, A S; Fattet, S; Kulesza, D W; Atamer, A; Elsing, A N; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2011). A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance. Molecular Cancer Research, 9(7):925-935.
Huertas, P; Cortés-Ledesma, F; Sartori, A A; Aguilera, A; Jackson, S P (2008). CDK targets Sae2 to control DNA-end resection and homologous recombination. Nature, 455:689-692.
Guerreiro, A S; Fattet, S; Fischer, B; Shalaby, T; Jackson, S P; Schoenwaelder, S M; Grotzer, M A; Delattre, O; Arcaro, A (2008). Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration. Clinical Cancer Research, 14(21):6761-6769.
Sartori, A A; Lukas, C; Coates, J; Mistrik, M; Fu, S; Bartek, J; Baer, R; Lukas, J; Jackson, S P (2007). Human CtIP promotes DNA end resection. Nature, 450(7169):509-514.